Pfizer Inc
PFENYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Aug 4, 2026Score 11/3053% above fair value
$30.67+0.15 (+0.49%)
Close on Nov 2, 2026Market cap $174.81BP/E 40.4Yield 5.61%
Pfizer Supplier Finance Program by Year
Supplier Finance Program — Obligations settled during year ($M) ($M)
Pfizer Supplier Finance Program: $2,229M in FY2025, down 18.6% from a year earlier.
Latest, FY2025
2,229
Period ended Dec 31, 2025
Change on a year earlier
-18.6%
2,740 in FY2024
History
2 years
Since FY2024
Sources
1
Form 10-K (filed 2026-02-26)
Where the FY2025 figure comes from
Source: Form 10-K (filed 2026-02-26) ↗
Reported in Form 10-K Supplier Finance Program Note.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Supplier Finance Program — Obligations settled during year ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2,229 | -18.6% | Form 10-K (filed 2026-02-26) ↗ |
| FY2024 | Dec 31, 2024 | 2,740 | – | Form 10-K (filed 2026-02-26) ↗ |
Cite this data
StockData. (2026). Pfizer Supplier Finance Program ($M), annual FY2024–FY2025 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/sfp-dec
See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.